Nonhuman Primate (NHP) Core Cellular Immunology Laboratory for AIDS Vaccine Research Development

非人灵长类动物 (NHP) 艾滋病疫苗研究开发核心细胞免疫学实验室

• 批准号: 10910829
• 负责人: AMITINDER KAUR
• 金额: $ 191.76万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-06-01 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10910829
• 关键词: AIDS Vaccines; Biological Assay; Cellular Immunology; Collaborations; Contractor; Contracts; Development; Flow Cytometry; HIV; HIV vaccine; Immune response; Immunize; Laboratories; National Institute of Allergy and Infectious Disease; Reproducibility; Research Personnel; SIV; SIV Vaccines; Site; Stains; Technology; United States National Institutes of Health; Vaccine Research; assay development; cytokine; design; enzyme linked immunospot assay; improved; nonhuman primate; research and development; simian human immunodeficiency virus; vaccine development; vaccine evaluation

The purpose of the Nonhuman Primate Core Cellular Immunology Laboratory for AIDS Vaccine Research and Development will be to support the development, conduct, and improvement of assays designed to evaluate and characterize the cellular immune responses of nonhuman primates that have been immunized with candidate HIV or SIV vaccines or infected with SIV, SHIV, or HIV in studies conducted at the NIAID SVEU contract sites or by NIH-supported investigators.

非人灵长类核心细胞免疫学实验室用于艾滋病疫苗研发的目的是支持开发、实施和改进旨在评价和表征在NIAID SVEU合同研究中心或NIH支持的研究者进行的研究中已接种候选HIV或SIV疫苗或感染SIV、SHIV或HIV的非人灵长类动物的细胞免疫应答的试验。